{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T05:42:15Z","timestamp":1773985335284,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007279","name":"Shanghai Municipal Health Bureau","doi-asserted-by":"publisher","award":["PW2024A-08"],"award-info":[{"award-number":["PW2024A-08"]}],"id":[{"id":"10.13039\/501100007279","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.tranon.2026.102678","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T14:04:09Z","timestamp":1769090649000},"page":"102678","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Phosphoglucomutase 5 suppresses gallbladder cancer progression by inhibiting lactate-driven STAT3 signaling"],"prefix":"10.1016","volume":"65","author":[{"given":"Wencong","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjiang","family":"Gou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingtai","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianyang","family":"Ao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinghan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tranon.2026.102678_bib0001","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5582\/bst.2020.01039","article-title":"The immunological characteristics of gallbladder carcinoma and advances in immunotherapy practices","volume":"15","author":"Cheng","year":"2021","journal-title":"Biosci. Trends."},{"key":"10.1016\/j.tranon.2026.102678_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1559465","article-title":"Advancing biliary tract malignancy treatment: emerging frontiers in cell-based therapies","volume":"16","author":"Ao","year":"2025","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.tranon.2026.102678_bib0003","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/pcmedi\/pbab017","article-title":"A case report of response to crizotinib in chemotherapy-refractory metastatic gallbladder cancer with met amplification and acquired resistance resulting from the loss of MET amplification","volume":"4","author":"Sun","year":"2021","journal-title":"Precision clinical medicine"},{"issue":"1","key":"10.1016\/j.tranon.2026.102678_bib0004","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s12935-023-03145-9","article-title":"Targeting the Endothelin-1 pathway to reduce invasion and chemoresistance in gallbladder cancer cells","volume":"23","author":"Rodas","year":"2023","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.tranon.2026.102678_bib0005","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1148\/rg.2021200087","article-title":"Gallbladder carcinoma and its differential diagnosis at MRI: what radiologists should know","volume":"41","author":"Lopes Vendrami","year":"2021","journal-title":"Radiograph."},{"issue":"10","key":"10.1016\/j.tranon.2026.102678_bib0006","doi-asserted-by":"crossref","first-page":"6314","DOI":"10.1097\/JS9.0000000000001456","article-title":"Single stage management of suspected gallbladder cancer guided by intraoperative frozen section analysis: a retrospective cohort study","volume":"110","author":"Banh","year":"2024","journal-title":"Int. J. Surg."},{"issue":"2","key":"10.1016\/j.tranon.2026.102678_bib0007","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.46912","article-title":"Propensity score analysis of chemotherapy use in patients with resectable gallbladder cancer","volume":"5","author":"Ozer","year":"2022","journal-title":"JAMA network open"},{"key":"10.1016\/j.tranon.2026.102678_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217156","article-title":"the sweet appetite of the tumor microenvironment","volume":"600","author":"Kooshan","year":"2024","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.tranon.2026.102678_bib0009","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.7150\/ijbs.91492","article-title":"Histone lactylation: from tumor lactate metabolism to epigenetic regulation","volume":"20","author":"Yu","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.tranon.2026.102678_bib0010","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jconrel.2022.12.003","article-title":"Targeting glycolysis for cancer therapy using drug delivery systems","volume":"353","author":"Huang","year":"2023","journal-title":"J. controll release"},{"key":"10.1016\/j.tranon.2026.102678_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1492050","article-title":"From metabolic byproduct to immune modulator: the role of lactate in tumor immune escape","volume":"15","author":"Jiang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tranon.2026.102678_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1563303","article-title":"Impact of lactate on immune cell function in the tumor microenvironment: mechanisms and therapeutic perspectives","volume":"16","author":"Gu","year":"2025","journal-title":"Front. Immunol."},{"issue":"14","key":"10.1016\/j.tranon.2026.102678_bib0013","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1039\/D2BM00650B","article-title":"Nanodrug regulates lactic acid metabolism to reprogram the immunosuppressive tumor microenvironment for enhanced cancer immunotherapy","volume":"10","author":"Tian","year":"2022","journal-title":"Biomater. Sci."},{"issue":"6","key":"10.1016\/j.tranon.2026.102678_bib0014","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.7150\/thno.105947","article-title":"Histone lactylation-driven B7-H3 expression promotes tumor immune evasion","volume":"15","author":"Ma","year":"2025","journal-title":"Theranostics."},{"issue":"11","key":"10.1016\/j.tranon.2026.102678_bib0015","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/s41419-020-03168-4","article-title":"Stroma secreted IL6 selects for \"stem-like\" population and alters pancreatic tumor microenvironment by reprogramming metabolic pathways","volume":"11","author":"Kesh","year":"2020","journal-title":"Cell Death. Dis."},{"issue":"1","key":"10.1016\/j.tranon.2026.102678_bib0016","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12935-024-03292-7","article-title":"Neighboring macrophage-induced alteration in the phenotype of colorectal cancer cells in the tumor budding area","volume":"24","author":"Kawamura","year":"2024","journal-title":"Cancer Cell Int."},{"issue":"2","key":"10.1016\/j.tranon.2026.102678_bib0017","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1158\/1535-7163.MCT-20-0599","article-title":"Targeting STAT3 with proteolysis Targeting chimeras and next-generation antisense oligonucleotides","volume":"20","author":"Shiah","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.tranon.2026.102678_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114168","article-title":"STAT3 signaling in prostate cancer progression and therapy resistance: an oncogenic pathway with diverse functions","volume":"158","author":"Sadrkhanloo","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tranon.2026.102678_bib0019","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jare.2021.03.008","article-title":"Fangchinoline diminishes STAT3 activation by stimulating oxidative stress and targeting SHP-1 protein in multiple myeloma model","volume":"35","author":"Jung","year":"2022","journal-title":"J. Adv. Res."},{"issue":"2","key":"10.1016\/j.tranon.2026.102678_bib0020","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1002\/mco2.124","article-title":"STAT3 pathway in cancers: past, present, and future","volume":"3","author":"Wang","year":"2022","journal-title":"MedComm"},{"key":"10.1016\/j.tranon.2026.102678_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1060372","article-title":"Meta-analysis of the effect of PGM on survival prognosis of tumor patients","volume":"12","author":"Zheng","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tranon.2026.102678_bib0022","doi-asserted-by":"crossref","first-page":"e7070","DOI":"10.7717\/peerj.7070","article-title":"PGM5: a novel diagnostic and prognostic biomarker for liver cancer","volume":"7","author":"Jiao","year":"2019","journal-title":"PeerJ."},{"issue":"8","key":"10.1016\/j.tranon.2026.102678_bib0023","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1615\/CritRevEukaryotGeneExpr.2022042376","article-title":"LncRNA PGM5-AS1 inhibits the progression of bladder cancer by regulating miR-587\/SLIT3 axis","volume":"32","author":"Duan","year":"2022","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"issue":"1","key":"10.1016\/j.tranon.2026.102678_bib0024","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12935-024-03402-5","article-title":"LncRNA PGM5-AS1 inhibits non-small cell lung cancer progression by targeting miRNA-423-5p\/SLIT2 axis","volume":"24","author":"Wang","year":"2024","journal-title":"Cancer Cell Int."},{"issue":"2","key":"10.1016\/j.tranon.2026.102678_bib0025","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/03936155251325846","article-title":"LncRNA PGM5-AS1 regulates cell functions and acts as a potential biomarker to predict prognosis in breast cancer","volume":"40","author":"Xiang","year":"2025","journal-title":"Int. J. Biol. Markers"},{"key":"10.1016\/j.tranon.2026.102678_bib0026","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5529770","article-title":"miR-1224-3p promotes breast cancer cell proliferation and migration through PGM5-mediated aerobic glycolysis","volume":"2021","author":"Ran","year":"2021","journal-title":"J. Oncol."},{"issue":"6","key":"10.1016\/j.tranon.2026.102678_bib0027","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.1007\/s10528-024-11011-0","article-title":"LncRNA PGM5-AS1 impairs the resistance of cervical cancer to cisplatin by regulating the hippo and PI3K-AKT pathways","volume":"63","author":"Wang","year":"2025","journal-title":"Biochem. Genet."},{"issue":"1","key":"10.1016\/j.tranon.2026.102678_bib0028","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12967-020-02572-w","article-title":"PGM5-AS1 impairs miR-587-mediated GDF10 inhibition and abrogates progression of prostate cancer","volume":"19","author":"Du","year":"2021","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.tranon.2026.102678_bib0029","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/17246008211068866","article-title":"Meta-analysis of the diagnostic performance of serum carbohydrate antigen 19-9 for the detection of gallbladder cancer","volume":"37","author":"Zhou","year":"2022","journal-title":"Int. J. Biol. Markers"},{"issue":"10","key":"10.1016\/j.tranon.2026.102678_bib0030","article-title":"A case of porcelain gallbladder showing high levels of CA19-9","volume":"16","author":"Kidogawa","year":"2024","journal-title":"Cureus."},{"issue":"6","key":"10.1016\/j.tranon.2026.102678_bib0031","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1097\/JS9.0000000000001379","article-title":"Long-term prognosis of patients with gallbladder carcinoma after curative-intent resection based on changes in the ratio of carbohydrate antigen 19-9 to total bilirubin (CA19-9\/TB): a multicenter retrospective cohort study","volume":"110","author":"Li","year":"2024","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.tranon.2026.102678_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.111877","article-title":"Lactate induces oxidative phosphorylation in osteoblasts via Gpr81-Stat3 signaling","volume":"133","author":"Hu","year":"2025","journal-title":"Cell. Signal."},{"key":"10.1016\/j.tranon.2026.102678_bib0033","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jare.2025.01.021","article-title":"Baicalin attenuates the immune escape of oral squamous cell carcinoma by reducing lactate accumulation in tumor microenvironment","volume":"77","author":"Cui","year":"2025","journal-title":"J. Adv. Res."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193652332600015X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193652332600015X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T04:18:54Z","timestamp":1773980334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193652332600015X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":33,"alternative-id":["S193652332600015X"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102678","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phosphoglucomutase 5 suppresses gallbladder cancer progression by inhibiting lactate-driven STAT3 signaling","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102678","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102678"}}